Henan Cancer Hospital: Esophageal Neoplasms trials

The registry lists 17 Esophageal Neoplasms studies with Henan Cancer Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 2Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation StudyNot yet recruitingNCT07778056
• AI-Driven Digital Twin and Drug Simulation for Esophageal CancerNot yet recruitingNCT07757022
• Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical TrialNot yet recruitingNCT07332221Phase 3
• Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital PathologyNot yet recruitingNCT07203690
• Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRINot yet recruitingNCT06833775
• Mechanistic Study on the Diagnosis of Esophageal Cancer Lymph Node Metastasis Using Spectral CT, Multimodal MRI, FAPI PET-CT, Pathology, and AI Evaluation SystemNot yet recruitingNCT06818214
• Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)RecruitingNCT06231680Phase 2
• Neoadjuvant Chemotherapy Compared With Surgery for Esophageal CarcinomaCompletedNCT05569668
• TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.Status unknownNCT05013697Phase 2
• TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
• Teripalimab Plus Chemotherapy in Local Advanced Esophageal CancerStatus unknownNCT03985670Phase 2
• The Application of 3T MRI in Esophageal CancerStatus unknownNCT03635619
• An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal CancerStatus unknownNCT03415815
• Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal CarcinomaCompletedNCT03413436Phase 4
• Apatinib Treatment for Advanced Esophagus CancerStatus unknownNCT03170310Phase 2
• Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal CancerWithdrawnNCT03110939Not applicable
• Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell CarcinomaCompletedNCT02395705Phase 3